Semaglutide Injection

A once-weekly GLP-1 RA for efficient blood sugar reduction

Semaglutide is a powerful once-weekly GLP-1 agonist injection clinically proven for effective blood sugar control in type 2 diabetes and significant weight management.

Indications:

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as: 

An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.

STRENGTH:

1.34mg/ml, 1.5ml (PFS) 

1.34mg/ml, 3ml (PFS/cartridge) 

2.68mg/ml, 3ml (PFS/cartridge)